The psychiatrist最新文献_第9页

Risk of cardiovascular malformations after exposure to paroxetine in pregnancy: meta-analysis 妊娠期暴露于帕罗西汀后心血管畸形的风险:荟萃分析

The psychiatrist Pub Date : 2013-06-01 DOI: 10.1192/PB.BP.111.035915

N. Painuly, Ritu Painuly, R. Heun, P. Sharan

{"title":"Risk of cardiovascular malformations after exposure to paroxetine in pregnancy: meta-analysis","authors":"N. Painuly, Ritu Painuly, R. Heun, P. Sharan","doi":"10.1192/PB.BP.111.035915","DOIUrl":"https://doi.org/10.1192/PB.BP.111.035915","url":null,"abstract":"Sciences Citation Index (SSCI), King’s Fund, DH-Data, CINAHL, Allied and Complementary Medicine Database (AMED) and British Nursing Index (BNI). Combinations of the terms ‘SSRI’, ‘selective serotonin reuptake inhibitor(s)’, ‘SRI’, ‘serotonin reuptake inhibitors’, ‘paroxetine’, ‘pregnancy’, ‘congenital malformation(s)’, ‘congenital defect(s)’, ‘cardiovascular malformation(s)’, ‘cardiac defect(s)’, ‘cardiovascular defect(s)’, ‘fetal malformation(s)’ and ‘fetal anomalies’ were used for the search. The search was restricted to articles published in English but there was no exclusion on the basis of country, ethical approval, etc. No grey literature was searched for this review. Each abstract/title and article was scrutinised by two of the authors (N.P. and R.P.) and the differences between them were resolved by consensus. Relevant articles were hand-searched for cross-references. The GlaxoSmithKline website was searched for recent data on paroxetine. To exclude repetitive data-sets, only the study with the most updated data was taken up for analysis. A repeat data search was done in August 2012, after the first review of this article, and results were updated.","PeriodicalId":89639,"journal":{"name":"The psychiatrist","volume":"42 1","pages":"198-203"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88869288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 9

Schema Therapy in Practice: An Introductory Guide to the Schema Mode Approach By Arnoud Arntz, Gitta Jacob, Wiley-Blackwell, 2013, £32.99, pb, 276 pp. ISBN: 9781119962861 实践中的图式治疗:图式模式方法入门指南，作者:Arnoud Arntz, Gitta Jacob, Wiley-Blackwell, 2013，£32.99,pb, 276 pp. ISBN: 9781119962861

The psychiatrist Pub Date : 2013-06-01 DOI: 10.1192/PB.BP.112.042234

Lawrence Martean

引用次数: 0

Psychiatrists' access to electronic laboratory results 精神科医生获得电子实验室结果的权利

The psychiatrist Pub Date : 2013-05-01 DOI: 10.1192/PB.BP.112.040543

M. Skelton, S. Thacker, A. Forbes-Haley, Mahendra Kumar, E. Holliday

引用次数: 0

The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society 迷幻药的复兴:重新评估迷幻药在21世纪精神病学和社会中的作用

The psychiatrist Pub Date : 2013-05-01 DOI: 10.1192/pb.bp.112.042275

S. Kohli

引用次数: 48

Drug information update: paliperidone palmitate for schizophrenia 药物信息更新:棕榈酸帕利哌酮治疗精神分裂症

The psychiatrist Pub Date : 2013-05-01 DOI: 10.1192/PB.BP.113.042739

Abraham M. Nussbaum, T. Stroup

{"title":"Drug information update: paliperidone palmitate for schizophrenia","authors":"Abraham M. Nussbaum, T. Stroup","doi":"10.1192/PB.BP.113.042739","DOIUrl":"https://doi.org/10.1192/PB.BP.113.042739","url":null,"abstract":"Aims and method To review the evidence for the use of paliperidone palmitate for people with schizophrenia and schizophrenia-like illnesses. We searched the Cochrane Schizophrenia Group Specialised Register and contacted the manufacturer of paliperidone palmitate, the US Food and Drug Administration, and the authors of papers that reported study results. Results Based on the evidence from five short-term, placebo-controlled studies, paliperidone palmitate is efficacious as an antipsychotic. Its adverse effects are similar to those of the closely related compounds paliperidone and risperidone. Extrapyramidal side-effects, weight gain and tachycardia are more common with paliperidone palmitate than placebo. Paliperidone palmitate was associated with substantial increases in serum prolactin but not with increased sexual side-effects in these studies. In two studies paliperidone palmitate was similar to depot risperidone. Clinical implications Paliperidone palmitate is an effective antipsychotic whose optimal dose appears to be between 39 and 234 mg every 4 weeks. We have no data assessing its long-term effectiveness or comparing it with any long-acting injected antipsychotic other than depot risperidone.","PeriodicalId":89639,"journal":{"name":"The psychiatrist","volume":"1 1","pages":"164-166"},"PeriodicalIF":0.0,"publicationDate":"2013-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89604107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Mental Health Act 1983: use of urgent treatment in clinical practice 1983年《精神卫生法》:在临床实践中使用紧急治疗

The psychiatrist Pub Date : 2013-05-01 DOI: 10.1192/PB.BP.112.038414

R. Yadav, A. Zigmond

引用次数: 1

From DSM-IV to DSM-5: an interim report from a cultural psychiatry perspective 从DSM-IV到DSM-5:文化精神病学视角的中期报告

The psychiatrist Pub Date : 2013-05-01 DOI: 10.1192/PB.BP.112.040998

N. Aggarwal

引用次数: 6

Psychology in the Bathroom 浴室里的心理学

The psychiatrist Pub Date : 2013-05-01 DOI: 10.1192/PB.BP.112.041426

Stephen Ginn